“…For this reason computer-aided drug discovery is being widely utilized to evaluate the potential of a compound as a drug to inhibit the disease-causing organisms, and molecular docking simulations in particular accelerates the choice of potential drugs for clinical trials [ [22] , [23] , [24] , [25] ]. In the case of phosphoramide compounds, some reports suggest them as possible inhibitors against SARS-CoV-2 by molecular docking studies that evaluate the binding interactions between the target protein of coronavirus and the tested drug compound [ [26] , [27] , [28] ].…”